{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:03Z","timestamp":1772165883114,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ebola disease (EBOD) is a highly lethal zoonotic viral hemorrhagic fever that is responsible for 41 outbreaks globally. Ebola transmission is a key driver of the magnitude and complexity of outbreaks, yet incidence rate during outbreaks is not fully studied. This study aimed to determine the incidence and predictors of Sudan Ebolavirus transmission during the 2022 outbreak in Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study leveraging surveillance records for individuals identified as contacts, and collected between September and December 2022 during the Sudan Ebolavirus Disease (SUVD) outbreak in Uganda. Data were extracted and analyzed via Stata\/SE 15. This analysis involved calculating incidence rates and assessing predictors of Ebola transmission through appropriate multivariable regression models, and controlling for potential confounders like sex, age, health worker, and place of contact. The study protocol was approved by the Busitema University Research Ethics Committee (BUFHS-2023-145). Individual informed consent was waived, and all the data were anonymized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      3140 contacts were included in the study, with 50.6% being female and a mean age of 24 years. The incidence rate of SUVD was 1.6 cases per 1,000 person-days of follow-up. Kaplan Meier survival function showed that the risk for being diagnosed with SUVD extended beyond 21 days, up to the 28th day postexposure. The incidence of SUVD in secondary transmission settings was 1.8 times higher than that in primary transmission settings (IRR\u2009=\u20091.81, 95% CI\u2009=\u20091.202\u20132.735;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). After controlling for sex, age, health worker, and place of contact, the significant predictors of SUVD transmission were high-risk contact status (aHR\u2009=\u20092.5, 95% CI: 1.68\u20133.72;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and male sex in secondary transmission settings (aHR\u2009=\u20092.14, 95% CI\u2009=\u20091.15\u20134.01;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study revealed a high incidence of Ebola among contacts, with cases emerging beyond the standard 21-day follow-up period. The incidence was notably higher in secondary transmission settings, with high-risk contacts and males being particularly vulnerable. These findings suggest the need to revise contact tracing protocols (extend beyond 21 days), and prioritize follow-up on the basis of risk stratification. Further research is warranted to explore sex-related differences in secondary transmission dynamics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-24739-0","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:50:47Z","timestamp":1762343447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and predictors of Sudan ebolavirus transmission among contacts in Uganda in 2022: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Muhamed","family":"Mulongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K. B.","family":"Matovu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yovani A. M.","family":"Lubaale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Olupot-Olupot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"1","key":"24739_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-020-0147-3","volume":"6","author":"ST Jacob","year":"2020","unstructured":"Jacob ST, et al. Ebola virus disease. Nat Reviews Disease Primers. 2020;6(1):13.","journal-title":"Nat Reviews Disease Primers"},{"key":"24739_CR2","volume-title":"International Classification of Diseases, Eleventh Revision (ICD-11)","author":"WHO","year":"2022","unstructured":"WHO. International Classification of Diseases, Eleventh Revision (ICD-11). World Health Organization; 2022."},{"issue":"5","key":"24739_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41579-019-0187-4","volume":"17","author":"JH Kuhn","year":"2019","unstructured":"Kuhn JH, et al. New filovirus disease classification and nomenclature. Nat Rev Microbiol. 2019;17(5):261\u20133.","journal-title":"Nat Rev Microbiol"},{"key":"24739_CR4","unstructured":"CDC. History of Ebola Disease Outbreaks. 2023 March 24, 2023 [Cited 2023 9\/9\/23]; Available from: https:\/\/www.cdc.gov\/vhf\/ebola\/history\/chronology.html"},{"issue":"3","key":"24739_CR5","first-page":"57","volume":"54","author":"B Zawili\u0144ska","year":"2014","unstructured":"Zawili\u0144ska B, Kosz-Vnenchak M. General introduction into the Ebola virus biology and disease. Folia Med Cracov. 2014;54(3):57\u201365.","journal-title":"Folia Med Cracov"},{"key":"24739_CR6","unstructured":"Formenty P. Brief introduction to Sudan virus disease (SVD) caused by Sudan Virus (SUDV) from the Sudan ebolavirus species, in WHO Public Health Laboratories Webinar Series. World Health Organization: Geneva Switzerland.\u00a02022."},{"key":"24739_CR7","volume-title":"Uganda Ebola Virus Disease Situation Report #93, in Ebola Situation Reports","author":"U MoH","year":"2023","unstructured":"MoH U. Uganda Ebola Virus Disease Situation Report #93, in Ebola Situation Reports. Ministry of Health, Uganda and World Health Organization: Kampala, Uganda; 2023."},{"issue":"3","key":"24739_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/INF.0000000000000638","volume":"34","author":"P Olupot-Olupot","year":"2015","unstructured":"Olupot-Olupot P. Ebola in children: epidemiology, clinical features, diagnosis and outcomes. Pediatr Infect Dis J. 2015;34(3):314\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"24739_CR9","volume-title":"Clinical manifestations and diagnosis of Ebola virusdisease, in UpToDate","author":"DS Chertow","year":"2020","unstructured":"Chertow DS, Bray M. Clinical manifestations and diagnosis of Ebola virusdisease, in UpToDate. Wolters Kluwer; 2020."},{"key":"24739_CR10","doi-asserted-by":"crossref","unstructured":"Boutzoukas AE et al. Secondary transmission of COVID-19 in K\u201312 schools: findings from 2 States. Pediatrics, 2022. 149(Supplement_2).","DOI":"10.1542\/peds.2021-054268K"},{"issue":"3","key":"24739_CR11","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.52225\/narra.v2i3.97","volume":"2","author":"AB Al-Tammemi","year":"2022","unstructured":"Al-Tammemi AB, et al. The outbreak of Ebola virus disease in 2022: A spotlight on a re-emerging global health menace. Narra J. 2022;2(3):e97.","journal-title":"Narra J"},{"issue":"2","key":"24739_CR12","first-page":"140","volume":"120","author":"NK Jaax","year":"1996","unstructured":"Jaax NK, et al. Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med. 1996;120(2):140\u201355.","journal-title":"Arch Pathol Lab Med"},{"key":"24739_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.coviro.2016.11.013","volume":"22","author":"P Lawrence","year":"2017","unstructured":"Lawrence P, et al. Human transmission of Ebola virus. Curr Opin Virol. 2017;22:51\u20138.","journal-title":"Curr Opin Virol"},{"issue":"11","key":"24739_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.micinf.2011.05.002","volume":"13","author":"DS Reed","year":"2011","unstructured":"Reed DS, et al. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microbes Infect. 2011;13(11):930\u20136.","journal-title":"Microbes Infect"},{"issue":"2","key":"24739_CR15","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/v7020511","volume":"7","author":"S Judson","year":"2015","unstructured":"Judson S, Prescott J, Munster V. Understanding Ebola virus transmission. Viruses. 2015;7(2):511\u201321.","journal-title":"Viruses"},{"key":"24739_CR16","volume-title":"Ebola and Marburg virus disease epidemics: preparedness, alert, control and evaluation","author":"WHO","year":"2014","unstructured":"WHO. Ebola and Marburg virus disease epidemics: preparedness, alert, control and evaluation. Geneva, Switzerland: World Health Organization; 2014."},{"issue":"5","key":"24739_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/infdis\/jiz511","volume":"221","author":"MR Reichler","year":"2020","unstructured":"Reichler MR, et al. Ebola patient virus cycle threshold and risk of household transmission of Ebola virus. J Infect Dis. 2020;221(5):707\u201314.","journal-title":"J Infect Dis"},{"issue":"10","key":"24739_CR18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/cid\/ciw114","volume":"62","author":"NE Dean","year":"2016","unstructured":"Dean NE, et al. Transmissibility and pathogenicity of Ebola virus: A systematic review and Meta-analysis of household secondary attack rate and asymptomatic infection. Clin Infect Dis. 2016;62(10):1277\u201386.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"24739_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jtbi.2004.03.006","volume":"229","author":"G Chowell","year":"2004","unstructured":"Chowell G, et al. The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J Theor Biol. 2004;229(1):119\u201326.","journal-title":"J Theor Biol"},{"key":"24739_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0196-0","volume":"12","author":"G Chowell","year":"2014","unstructured":"Chowell G, Nishiura H. Transmission dynamics and control of Ebola virus disease (EVD): a review. BMC Med. 2014;12:1\u201317.","journal-title":"BMC Med"},{"key":"24739_CR21","unstructured":"Mbabazi FK et al. An Optimal Control for Ebola Virus Disease with a Convex Incidence Rate: Imputing from the Outbreak in Uganda. Qeios, 2023."},{"issue":"Supplement_1","key":"24739_CR22","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1086\/514284","volume":"179","author":"SF Dowell","year":"1999","unstructured":"Dowell SF, et al. Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999;179(Supplement_1):S87\u201391.","journal-title":"J Infect Dis"},{"issue":"5","key":"24739_CR23","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/ije\/dyac081","volume":"51","author":"N Duffy","year":"2022","unstructured":"Duffy N, et al. Risk factors for Ebola virus disease among household care providers, Sierra Leone, 2015. Int J Epidemiol. 2022;51(5):1457\u201368.","journal-title":"Int J Epidemiol"},{"issue":"suppl 3","key":"24739_CR24","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.1093\/infdis\/jiw254","volume":"214","author":"P Vetter","year":"2016","unstructured":"Vetter P, et al. Ebola virus shedding and transmission: review of current evidence. J Infect Dis. 2016;214(suppl 3):S177\u201384.","journal-title":"J Infect Dis"},{"issue":"1","key":"24739_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4314\/ahs.v15i1.45","volume":"15","author":"SI Okware","year":"2015","unstructured":"Okware SI, et al. Managing Ebola from rural to urban slum settings: experiences from Uganda. Afr Health Sci. 2015;15(1):312\u201321.","journal-title":"Afr Health Sci"},{"issue":"9","key":"24739_CR26","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3201\/eid2209.160416","volume":"22","author":"KA Lindblade","year":"2016","unstructured":"Lindblade KA, et al. Secondary infections with Ebola virus in rural communities, Liberia and Guinea, 2014\u20132015. Emerg Infect Dis. 2016;22(9):1653.","journal-title":"Emerg Infect Dis"},{"key":"24739_CR27","volume-title":"Uganda Ebola Virus Disease Situation Report No 69, in Uganda EVD SitRep #69","author":"Ministry of Health, U","year":"2022","unstructured":"Ministry of Health, U. Uganda Ebola Virus Disease Situation Report No 69, in Uganda EVD SitRep #69. Kampala; 2022."},{"issue":"11","key":"24739_CR28","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3201\/eid0911.030339","volume":"9","author":"P Francesconi","year":"2003","unstructured":"Francesconi P, et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis. 2003;9(11):1430.","journal-title":"Emerg Infect Dis"},{"issue":"9992","key":"24739_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(15)61446-5","volume":"386","author":"JR Glynn","year":"2015","unstructured":"Glynn JR. Age-specific incidence of Ebola virus disease. Lancet. 2015;386(9992):432.","journal-title":"Lancet"},{"key":"24739_CR30","volume-title":"Epidemiology beyond the basics fourth","author":"M Szklo","year":"2019","unstructured":"Szklo M, Nieto J. Epidemiology beyond the basics fourth. Burlington, Massachusetts: Jones & Bartlett Learning; 2019."},{"issue":"4","key":"24739_CR31","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.idc.2019.08.005","volume":"33","author":"E Nicastri","year":"2019","unstructured":"Nicastri E, et al. Ebola virus disease: epidemiology, clinical features, management, and prevention. Infect Dis Clin North Am. 2019;33(4):953\u201376.","journal-title":"Infect Dis Clin North Am"},{"key":"24739_CR32","unstructured":"Okware SI. Three ebola outbreaks in Uganda 2000\u20132011. 2015."},{"key":"24739_CR33","volume-title":"Ebola and Marburg virus disease epidemics: preparedness, alert, control and evaluation","author":"WHO","year":"2014","unstructured":"WHO. Ebola and Marburg virus disease epidemics: preparedness, alert, control and evaluation. World Health Organization: WHO; 2014."},{"issue":"1","key":"24739_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1186\/s12879-024-09391-0","volume":"24","author":"A Komakech","year":"2024","unstructured":"Komakech A, et al. Sudan virus disease super-spreading, uganda, 2022. BMC Infect Dis. 2024;24(1):520.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"24739_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12879-024-09439-1","volume":"24","author":"SM Migamba","year":"2024","unstructured":"Migamba SM, et al. Individual and household risk factors for Ebola disease among household contacts in Mubende and Kassanda districts, uganda, 2022. BMC Infect Dis. 2024;24(1):543.","journal-title":"BMC Infect Dis"},{"issue":"Supplement1","key":"24739_CR36","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1086\/514318","volume":"179","author":"AK Rowe","year":"1999","unstructured":"Rowe AK, et al. Clinical, virologic, and Immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, kikwit, Democratic Republic of the congo. J Infect Dis. 1999;179(Supplement1):S28\u201335.","journal-title":"J Infect Dis"},{"issue":"1","key":"24739_CR37","doi-asserted-by":"publisher","first-page":"e1002057","DOI":"10.1371\/journal.pbio.1002057","volume":"13","author":"G Chowell","year":"2015","unstructured":"Chowell G, Nishiura H. Characterizing the transmission dynamics and control of Ebola virus disease. PLoS Biol. 2015;13(1):e1002057.","journal-title":"PLoS Biol"},{"issue":"7","key":"24739_CR38","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1093\/aje\/kwz090","volume":"188","author":"A Robert","year":"2019","unstructured":"Robert A, et al. Determinants of transmission risk during the late stage of the West African Ebola epidemic. Am J Epidemiol. 2019;188(7):1319\u201327.","journal-title":"Am J Epidemiol"},{"key":"24739_CR39","first-page":"560","volume":"6","author":"N Shakiba","year":"2021","unstructured":"Shakiba N, et al. Effects of environmental variability on superspreading transmission events in stochastic epidemic models. Infect Dis Model. 2021;6:560\u201383.","journal-title":"Infect Dis Model"},{"key":"24739_CR40","doi-asserted-by":"crossref","unstructured":"Zinszer K et al. Spatial determinants of Ebola virus disease risk for the West African epidemic. PLoS Curr, 2017. 9.","DOI":"10.1371\/currents.outbreaks.b494f2c6a396c72ec24cb4142765bb95"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24739-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24739-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24739-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:50:51Z","timestamp":1762343451000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24739-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24739"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24739-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5305870\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the Busitema University Research Ethics Committee (Reference number BUFHS-2023-145) and the Uganda National Council of Science and Technology (UNCT) (Reference number HS3947ES). The application for a waiver of consent was approved by BUFHS REC because the study used secondary data. Permission was also obtained from the District Chief Administrative Officers in Mubende and Kassanda districts to access outbreak records and extract data for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3793"}}